Cresco Labs (CRLBF) Revenue (2020 - 2026)
Cresco Labs (CRLBF) reported Revenue of $151.3 million for Q1 2026, down 8.71% on a YoY basis from $165.8 million in Q1 2025, and down 6.33% quarter-over-quarter from $161.6 million in Q4 2025.
Cresco Labs (CRLBF) Revenue (2020 - 2026) Analysis & Trends
Cresco Labs has reported Revenue for 7 years, with the latest figure at $151.3 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 8.71% year-over-year to $151.3 million; the trailing twelve-month figure through Mar 2026 stood at $641.4 million (down 9.12% YoY), and the FY2025 full-year result was $655.8 million, down 9.46% from the prior year.
- Revenue for Q1 2026 stood at $151.3 million, down from $161.6 million in the prior quarter.
- The five-year high for Revenue was $218.2 million in Q2 2022, with the low at $151.3 million in Q1 2026.
- Historically, Revenue has averaged $185.0 million across 5 years, with a median of $184.4 million in 2024.
- Annual changes were most pronounced in 2022 — Revenue increased 3.93% — and 2025, when it decreased 11.25%.
- Cresco Labs' Revenue stood at $199.6 million in 2022, then retreated by 5.68% to $188.2 million in 2023, then retreated by 6.55% to $175.9 million in 2024, then decreased by 8.16% to $161.6 million in 2025, then declined by 6.33% to $151.3 million in 2026.
- The last three Revenue figures came in at $151.3 million (Q1 2026), $161.6 million (Q4 2025), and $164.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 151.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.33 Mn |
| Dec 31, 2025 | 161.55 Mn |
| Sep 30, 2025 | 164.91 Mn |
| Jun 30, 2025 | 163.62 Mn |
| Mar 31, 2025 | 165.76 Mn |
| Dec 31, 2024 | 175.91 Mn |
| Sep 30, 2024 | 179.78 Mn |
| Jun 30, 2024 | 184.36 Mn |
| Mar 31, 2024 | 184.30 Mn |
| Dec 31, 2023 | 188.24 Mn |
| Sep 30, 2023 | 190.56 Mn |
| Jun 30, 2023 | 197.89 Mn |
| Mar 31, 2023 | 194.20 Mn |
| Dec 31, 2022 | 199.58 Mn |
| Sep 30, 2022 | 210.48 Mn |
| Jun 30, 2022 | 218.23 Mn |
| Mar 31, 2022 | 214.39 Mn |
| Dec 31, 2021 | 217.79 Mn |
| Sep 30, 2021 | 215.48 Mn |
| Jun 30, 2021 | 209.98 Mn |